Moreover, IGF1, an insulin-linked peptide targeted by miR-483, was investigated as it has been shown that insulin sensitivity is more prone to be decreased by the body fat in PCOS patients, implying a greater demand for insulin to satisfy metabolic needs. Here, INS is linked to polycystic ovary syndrome.